Validity and Reliability of the Migraine-Treatment Optimization Questionnaire

Our aim was to establish the validity and reliability of a patient-rated Migraine Treatment Optimization Questionnaire (M-TOQ in primary care. Patients who met International Classification of Headache Disorders, 2nd edn criteria for migraine completed a 19-item questionnaire containing candidate items for the M-TOQ and three questionnaires designed to test convergent/construct validity [Migraine Disability Assessment Scale (MIDAS), Headache Impact Test (HIT)-6 and Migraine-Specific Quality of Life Scale (MSSQoL)]. A 15-item (M-TOQ15) and a five-item (M-TOQ-5) questionnaire were derived. Two hundred and fifty-three adult patients were recruited. Five treatment optimization domains were identified: functioning, rapid relief, consistency of relief, risk of recurrence and tolerability; with Cronbach alphas of 0.70-0.84. The Cronbach α for M-TOQ-15 was 0.85, and it correlated well with MIDAS, HIT-6 and MSQoL (r = 0.33-0.44). The Cronbach α for M-TOQ-5 was 0.66, and it also correlated well with the three questionnaires (r = 0.33-0.41). The utility of the M-TOQ for assessing treatment benefit in research (M-TOQ-5) and primary care (M-TOQ-5) should be further validated.

[1]  R. Lipton,et al.  Migraine prevalence, disease burden, and the need for preventive therapy , 2007, Neurology.

[2]  P. Tfelt-Hansen.  A Review of Evidence-Based Medicine and Meta-Analytic Reviews in Migraine , 2006, Cephalalgia : an international journal of headache.

[3]  C. Lucas.  Strategies to Improve Migraine Treatment Results , 2006 .

[4]  E. Loder,et al.  Evaluating the triptans. , 2005, The American journal of medicine.

[5]  J. Goldstein,et al.  Evaluating the safety and tolerability profile of acute treatments for migraine. , 2005, The American journal of medicine.

[6]  R. Lipton,et al.  Migraine practice patterns among neurologists , 2004, Neurology.

[7]  A. Dowson,et al.  Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire , 2004, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.

[8]  A. Dowson,et al.  A six-item short-form survey for measuring headache impact: The HIT-6™ , 2003, Quality of Life Research.

[9]  J. Olesen,et al.  The International Classification of Headache Disorders: 2nd edition , 2003, The Lancet Neurology.

[10]  Anaes.  [Recommendations for clinical practice. Review of diagnosis and treatment of migraine in the adult and child October 2002. Professional recommendations and references: economic evaluation service]. , 2003, Revue neurologique.

[11]  Bonnetblanc Jm.  Les recommandations pour la pratique clinique , 2002 .

[12]  R. Lipton,et al.  Migraine in the United States: Epidemiology and patterns of health care use , 2002, Neurology.

[13]  R. Lipton,et al.  Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials , 2001, The Lancet.

[14]  W. Stewart,et al.  Clinical Utility of an Instrument Assessing Migraine Disability: The Migraine Disability Assessment (MIDAS) Questionnaire , 2001, Headache.

[15]  R. Lipton,et al.  Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II , 2001, Headache.

[16]  R. Lipton,et al.  Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability , 2001, Neurology.

[17]  S. Silberstein.  Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) , 2000, Neurology.

[18]  Bryan C. Hurst,et al.  Further Development and Testing of the Migraine‐Specific Quality of Life (MSQOL) Measure , 2000, Headache.

[19]  M Pringle,et al.  Do Minutes Count? Consultation Lengths in General Practice , 1998, Journal of health services research & policy.

[20]  G. Albrecht,et al.  Satisfaction as a determinant of compliance. , 1998, Community dentistry and oral epidemiology.